Status:

COMPLETED

PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer

Lead Sponsor:

Case Comprehensive Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Childhood Cancer

Eligibility:

All Genders

Up to 17 years

Phase:

NA

Brief Summary

This pilot clinical trial studies how well positron emission tomography (PET)/magnetic resonance imaging (MRI) works compared to PET/computed tomography (CT) in diagnosing younger patients with cancer...

Detailed Description

PRIMARY OBJECTIVES: I. Determine the diagnostic accuracy of PET/MRI as compared to the standard of reference PET/CT in lesion detection and lesion characterization. SECONDARY OBJECTIVES: I. Obtain ...

Eligibility Criteria

Inclusion

  • Patients who are referred by their physician for clinically indicated diagnostic fludeoxyglucose F 18 (18F-FDG) PET/CT (with or without clinically indicated diagnostic MRI)
  • Subjects with malignancies including hematologic disorders
  • Subjects NOT requiring sedation or anesthesia
  • Stable physical medical conditions (patients conscious and comfortable, scheduled for an elective diagnostic imaging)

Exclusion

  • Subjects who are unable or unwilling to give their assent to both examinations if \> 7 years old
  • Subjects requiring general anesthesia or sedation in order to undergo PET/CT or MRI
  • Subjects unable to undergo magnetic resonance (MR) scanning due to exclusion by University Hospitals-Case Medical Center restriction policies for Magnetic Resonance Imaging (UHCMC MRI restriction policies) as mentioned in the standard UHCMC MRI informed consent form
  • Previously known allergies against MRI contrast agents (exclusion criterion only for contrast enhanced MRI)
  • Pregnant or breast feeding subjects, as determined by standard questionnaire administered prior to scanning

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2016

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT02287636

Start Date

April 1 2013

End Date

April 1 2016

Last Update

February 24 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Cleveland, Ohio, United States, 44106-5065